spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transferase PDB id
3fpd
Jmol
Contents
Protein chains
261 a.a. *
Ligands
SAH ×2
Q4A ×2
Metals
_ZN ×8
Waters ×119
* Residue conservation analysis
PDB id:
3fpd
Name: Transferase
Title: G9a-like protein lysine methyltransferase inhibition by bix- 01294
Structure: Histone-lysine n-methyltransferase, h3 lysine-9 specific 5. Chain: a, b. Fragment: unp residues 975-1235, set domain. Synonym: histone h3-k9 methyltransferase 5, h3-k9-hmtase 5, euchromatic histone-lysine n-methyltransferase 1, eu- hmtase1, g9a-like protein 1, glp1, lysine n- methyltransferase 1d. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: ehmt1, euhmtase1, kiaa1876, kmt1d. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.40Å     R-factor:   0.221     R-free:   0.262
Authors: Y.Chang,X.Zhang,J.R.Horton,X.Cheng
Key ref:
Y.Chang et al. (2009). Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat Struct Biol, 16, 312-317. PubMed id: 19219047 DOI: 10.1038/nsmb.1560
Date:
05-Jan-09     Release date:   17-Feb-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q9H9B1  (EHMT1_HUMAN) -  Histone-lysine N-methyltransferase EHMT1
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1298 a.a.
261 a.a.
Key:    PfamA domain  PfamB domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.1.1.43  - Histone-lysine N-methyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: S-adenosyl-L-methionine + L-lysine-[histone] = S-adenosyl-L-homocysteine + N6-methyl-L-lysine-[histone]
S-adenosyl-L-methionine
+ L-lysine-[histone]
=
S-adenosyl-L-homocysteine
Bound ligand (Het Group name = SAH)
corresponds exactly
+ N(6)-methyl-L-lysine-[histone]
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     nucleus   1 term 
  Biological process     chromatin modification   1 term 
  Biochemical function     zinc ion binding     2 terms  

 

 
    Added reference    
 
 
DOI no: 10.1038/nsmb.1560 Nat Struct Biol 16:312-317 (2009)
PubMed id: 19219047  
 
 
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.
Y.Chang, X.Zhang, J.R.Horton, A.K.Upadhyay, A.Spannhoff, J.Liu, J.P.Snyder, M.T.Bedford, X.Cheng.
 
  ABSTRACT  
 
Histone lysine methylation is an important epigenetic mark that regulates gene expression and chromatin organization. G9a and G9a-like protein (GLP) are euchromatin-associated methyltransferases that repress transcription by methylating histone H3 Lys9. BIX-01294 was originally identified as a G9a inhibitor during a chemical library screen of small molecules and has previously been used in the generation of induced pluripotent stem cells. Here we present the crystal structure of the catalytic SET domain of GLP in complex with BIX-01294 and S-adenosyl-L-homocysteine. The inhibitor is bound in the substrate peptide groove at the location where the histone H3 residues N-terminal to the target lysine lie in the previously solved structure of the complex with histone peptide. The inhibitor resembles the bound conformation of histone H3 Lys4 to Arg8, and is positioned in place by residues specific for G9a and GLP through specific interactions.
 
  Selected figure(s)  
 
Figure 1.
(a) Progression of methylation as a function of reaction time. The arrows point to the conditions used for subsequent inhibition studies. (b) The inhibition on G9a and GLP by various concentrations of BIX-01294. (c) Variation in the relative abundance of each peptide species (me0, me1 and me2) as a function of BIX-01294 concentration. (d) Ras-mediated epigenetic silencing of Fas is derepressed with both BIX-01294 (BIX) and 5-aza treatments. (e) Methylation of DNMT1 by G9a and GLP and inhibition by BIX-01294; the autoradiography image and relative activity by TCA counts. Error bars in b, c and e indicate s.d. for two duplicated measurements.
Figure 2.
(a) Structure of the GLP SET domain. (b) AdoHcy and BIX-01294 bind in two distinctive pockets. (c,d) BIX-01294 binds in the substrate peptide binding groove (c), which is occupied by H3K4–H3R8 (d; PDB 2RFI^12). (e) Superimposition of H3 peptide (yellow) and BIX-01294. (f) Water molecules (small red spheres) occupy the target lysine binding channel.
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: Nat Struct Biol (2009, 16, 312-317) copyright 2009.  
  Figures were selected by the author.  
 
 
    Author's comment    
 
  In panel Figure 1e, the concentration of inhibitor is in uM (micro M).  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  21141727 A.K.Upadhyay, and X.Cheng (2011).
Dynamics of histone lysine methylation: structures of methyl writers and erasers.
  Prog Drug Res, 67, 107-124.  
21415849 K.Plath, and W.E.Lowry (2011).
Progress in understanding reprogramming to the induced pluripotent state.
  Nat Rev Genet, 12, 253-265.  
20951770 R.A.Varier, and H.T.Timmers (2011).
Histone lysine methylation and demethylation pathways in cancer.
  Biochim Biophys Acta, 1815, 75-89.  
21243713 S.Krishnan, S.Horowitz, and R.C.Trievel (2011).
Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
  Chembiochem, 12, 254-263.  
20567762 A.M.Quinn, A.Allali-Hassani, M.Vedadi, and A.Simeonov (2010).
A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors.
  Mol Biosyst, 6, 782-788.  
19937593 C.S.Beshara, C.E.Jones, K.D.Daze, B.J.Lilgert, and F.Hof (2010).
A simple calixarene recognizes post-translationally methylated lysine.
  Chembiochem, 11, 63-66.  
20084102 H.Wu, J.Min, V.V.Lunin, T.Antoshenko, L.Dombrovski, H.Zeng, A.Allali-Hassani, V.Campagna-Slater, M.Vedadi, C.H.Arrowsmith, A.N.Plotnikov, and M.Schapira (2010).
Structural biology of human H3K9 methyltransferases.
  PLoS One, 5, e8570.
PDB codes: 2igq 2o8j 2qpw 2r3a 2rfi 3hna
20056891 I.Maze, H.E.Covington, D.M.Dietz, Q.LaPlant, W.Renthal, S.J.Russo, M.Mechanic, E.Mouzon, R.L.Neve, S.J.Haggarty, Y.Ren, S.C.Sampath, Y.L.Hurd, P.Greengard, A.Tarakhovsky, A.Schaefer, and E.J.Nestler (2010).
Essential role of the histone methyltransferase G9a in cocaine-induced plasticity.
  Science, 327, 213-216.  
20236310 M.S.Cosgrove, and A.Patel (2010).
Mixed lineage leukemia: a structure-function perspective of the MLL1 protein.
  FEBS J, 277, 1832-1842.  
20094655 M.Sakurai, N.R.Rose, L.Schultz, A.M.Quinn, A.Jadhav, S.S.Ng, U.Oppermann, C.J.Schofield, and A.Simeonov (2010).
A miniaturized screen for inhibitors of Jumonji histone demethylases.
  Mol Biosyst, 6, 357-364.  
20739309 M.Wang, M.W.Mok, H.Harper, W.H.Lee, J.Min, S.Knapp, U.Oppermann, B.Marsden, and M.Schapira (2010).
Structural genomics of histone tail recognition.
  Bioinformatics, 26, 2629-2630.  
20159995 R.Collins, and X.Cheng (2010).
A case study in cross-talk: the histone lysine methyltransferases G9a and GLP.
  Nucleic Acids Res, 38, 3503-3511.  
20659682 T.J.Wigle, L.M.Provencher, J.L.Norris, J.Jin, P.J.Brown, S.V.Frye, and W.P.Janzen (2010).
Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis.
  Chem Biol, 17, 695-704.  
20944599 T.K.Kelly, D.D.De Carvalho, and P.A.Jones (2010).
Epigenetic modifications as therapeutic targets.
  Nat Biotechnol, 28, 1069-1078.  
21243036 W.P.Janzen, T.J.Wigle, J.Jin, and S.V.Frye (2010).
Epigenetics: Tools and Technologies.
  Drug Discov Today Technol, 7, e59-e65.  
20210320 X.Cheng, and R.M.Blumenthal (2010).
Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.
  Biochemistry, 49, 2999-3008.  
19891491 F.Liu, X.Chen, A.Allali-Hassani, A.M.Quinn, G.A.Wasney, A.Dong, D.Barsyte, I.Kozieradzki, G.Senisterra, I.Chau, A.Siarheyeva, D.B.Kireev, A.Jadhav, J.M.Herold, S.V.Frye, C.H.Arrowsmith, P.J.Brown, A.Simeonov, M.Vedadi, and J.Jin (2009).
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.
  J Med Chem, 52, 7950-7953.
PDB code: 3k5k
  19961595 L.Colin, and C.Van Lint (2009).
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
  Retrovirology, 6, 111.  
19721445 R.A.Copeland, M.E.Solomon, and V.M.Richon (2009).
Protein methyltransferases as a target class for drug discovery.
  Nat Rev Drug Discov, 8, 724-732.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.